Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
about
A comparative study of experimental mouse models of central nervous system demyelination.The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosisCytokines in immunotherapy of experimental uveitis.Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2Cytokine-based immunointervention in the treatment of autoimmune diseases.Gene therapy in autoimmune, demyelinating disease of the central nervous system.Vectors for the treatment of autoimmune disease.Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.Amelioration of experimental autoimmune encephalomyelitis in IL-4Ralpha-/- mice implicates compensatory up-regulation of Th2-type cytokines.IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivoEnhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental designDiverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.In situ production of therapeutic monoclonal antibodies.Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification.IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats.Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis.Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5.The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception.HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates.Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.Chemokines and chemokine receptors in inflammation of the CNS.
P2860
Q33717475-95A56114-AF14-463E-8A90-F5EC4BD96A0DQ34413247-FE5A501A-7825-4BC2-8CAA-71313AAB331DQ34993224-3C4C4F27-A6B4-499A-AA9B-793140CE7944Q35054374-37CD51C7-4553-4DFB-9D3A-2872E17F7FABQ35109131-E88E024D-3238-473E-BA46-091325A5EEBCQ35122159-DD4F517E-5B1A-4A26-B56F-5D190EB60231Q35122178-4B327036-66CA-4348-958E-02DFD53E2FCAQ35589934-8BC89765-060A-452E-A668-8FD290600A64Q36153387-C6AB02C8-D877-46BF-B77C-4A34C1358C75Q36187725-6CE4A9C5-39A0-4D16-AADD-52F1EB03A401Q36677698-8F63818B-8C96-4734-A501-327098EC1DA3Q36734874-5F151DC4-159D-4AF2-975F-424EADFFC1D7Q36976119-E5B0DB50-C02F-4FFA-B490-27124F9A6064Q37243842-8DF0D1FE-8D6A-4752-B209-3341F4F6171CQ37410601-6FF76D89-265E-4375-8D0E-7B397C0ECF73Q38314210-4AD8E6A8-0076-464A-AD41-A94659D3E5F9Q39756417-DB8846A6-F1C7-4DBA-8662-EA6D227CD982Q40333178-A268C979-AD56-44BA-A6A5-B958149B3015Q43247720-D211CF2B-E69D-4DC0-B83C-8CB0E3F4F257Q43735065-5D84F07B-4894-4F11-9D43-365C9FF107E5Q43749965-A522B277-C25D-4936-81FB-946C93EB348FQ44086097-1FADAF5E-B798-4659-8EA0-E18A044AD31AQ44673491-E26889A8-AE8F-4A58-AD5A-C501EE40576EQ45872162-0E979A13-8AC4-43A2-855F-3FFF5E1D5668Q45882279-6B0EAABA-2782-4A5E-9946-596363125A94Q48829652-50E018B2-0FFA-4FE8-8D17-107EEC7D8438
P2860
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Central nervous system gene th ...... omyelitis in Biozzi AB/H mice.
@en
Central nervous system gene th ...... omyelitis in Biozzi AB/H mice.
@nl
type
label
Central nervous system gene th ...... omyelitis in Biozzi AB/H mice.
@en
Central nervous system gene th ...... omyelitis in Biozzi AB/H mice.
@nl
prefLabel
Central nervous system gene th ...... omyelitis in Biozzi AB/H mice.
@en
Central nervous system gene th ...... omyelitis in Biozzi AB/H mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Central nervous system gene th ...... lomyelitis in Biozzi AB/H mice
@en
P2093
P2860
P2888
P356
10.1038/SJ.GT.3301357
P577
2001-01-01T00:00:00Z
P5875
P6179
1049485057